Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-06-27
2011-12-06
Hanley, Susan (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C422S022000, C422S024000, C549S282000
Reexamination Certificate
active
08071642
ABSTRACT:
Water-soluble dimethyl amino ethyl ether psoralens useful in the treatment of proliferative skin disorders, microbial infections and diseases, disorders of the blood and bone marrow of mammals and in microbiocidal compositions for sterilization of blood and blood products and surgical implants and inhibition of microbial growth in industrial applications are provided.
REFERENCES:
patent: 4124598 (1978-11-01), Hearst et al.
patent: 4130568 (1978-12-01), Confalone et al.
patent: 4294822 (1981-10-01), Kaufman
patent: 4429138 (1984-01-01), Goupil
patent: 4950770 (1990-08-01), Heindel et al.
patent: 5356929 (1994-10-01), Heindel et al.
patent: 5473083 (1995-12-01), Heindel et al.
patent: 2009/0155224 (2009-06-01), Laskin et al.
Bacchichetti et al. Photodermatology (1985) 2:221-228.
webpage from www.perkinelmer.com/life sciences, 4 pages, downloaded Jun. 1, 2011.
Jabin, I. et al., “Synthetic Approaches to 3-Substituted-5′-(N-pyridiniummethyl)-4′, 5′—dihydropsoralen ,”J. Heterocyclic Chem., vol. 37, pp. 31-39 (2000).
Heindel, N. D. et al., “Transfer Hydrogenations of Furocoumarin Derivatives,”J. Org. Chem., vol. 48, pp. 3817-3819 (1983).
Foster, N. I. et al., “A Condition Variation Study for Radioiodination Via Triazene Intermediates,”J. Radioanalytical Chem., 65:1-2, pp. 95-105 (1981).
Yurkow, E. J., et al., “Mechanism of Action of Psoralens: Isobologram Analysis Reveals that Ultraviolet Light Potentiation of Psoralen Action is not Additive but Synergistic,”Cancer Chemother. Pharmacol., vol. 27, pp. 315-319 (1991).
Heindel, N. D. et al., “Nitrations of 4′, 5′ —Dihydropsoralens: A Route to Radiopharmaceutical Precursores,”J. Heterocyclic Chem. vol. 23, pp. 1579-1582 (1986).
Anderson, T. F., et al., “Psoralen Photochemotherapy of Cutaneous Disorders,”Ann. Rev. Pharmacol. Toxicol., vol. 20, pp. 235-257 (1980).
Kitano, K, et al., “Macrophage-Active Colony-Stimulating Factors Enhance Human Immunodeficiency Virus Type 1 Infection in Bone Marrow Stem Cells,”Blood, 77:8, pp. 1699-1705 (1991).
Laskin, J. D. et al., “Basis for Natural Variation in Sensitivity to 5-Fluorouracil in Mouse and Human Cells in Culture,”Cancer Research, vol. 39, pp. 383-390 (1979).
Hearst, J. E. et al., “Photochemistry of the Psoralens,”Chem. Res. Toxicol., 2:2, pp. 69-75 (1989).
Folks, T. M., et al., “Infection and Replication of HIV-1 in Purified Progenitor Cells of Normal Human Bone Marrow,”Science, 242:4880, pp. 919-922 (1988).
Heck Diane E.
Heindel Ned D.
Laskin Jeffrey D.
Fox Rothschild LLP
Hanley Susan
Lehigh University
Rutgers The State University of New Jersey
University of Medicine and Dentistry of New Jersey
LandOfFree
Dimethyl amino ethyl ether psoralens and methods for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dimethyl amino ethyl ether psoralens and methods for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dimethyl amino ethyl ether psoralens and methods for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4315543